The Aging Proteome: Clocks, Cohorts, and Clinical Trials
In this GEN webinar, two experts will show how ultra-sensitive, multiplexed proteomics can measure both the pace of aging and the effects of interventions designed to change it. The post The Aging Proteome: Clocks, Cohorts, and Clinical Trials appeared first on GEN - Genetic Engineering and Biotechnology News .
Panelists Xiao-Jun Ma and Michael J. Corley shared insights on the aging proteome during a GEN webinar on December 1, 2026. Ma, CTO of Alamar Biosciences, highlighted the importance of precise and reproducible biomarkers in understanding aging's impact on chronic diseases. Corley, an associate professor at UCSD, emphasized the potential of ultra-sensitive, multiplexed proteomics in measuring aging's pace and intervention effects.
The experts discussed how completed clinical trials with banked samples could facilitate rapid screening of candidate interventions, ultimately contributing to the development of novel biomarkers and therapeutics for longevity.
Written by urgent.news from GEN Biotechnology's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
